Welcome to LookChem.com Sign In|Join Free

CAS

  • or

219660-71-6

Post Buying Request

219660-71-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

219660-71-6 Usage

Description

5-bromo-3-(phthalimidomethyl)pyridine is a chemical compound that features a pyridine ring with a bromine atom at the 5th position and a phthalimido group attached to the 3-carbon. 5-bromo-3-(phthalimidomethyl)pyridine is recognized for its versatile reactivity and utility in organic synthesis and pharmaceutical development.

Uses

Used in Organic Synthesis:
5-bromo-3-(phthalimidomethyl)pyridine is used as a reagent for the introduction of the phthalimido group onto various molecules, facilitating the creation of new chemical entities and structures.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 5-bromo-3-(phthalimidomethyl)pyridine is utilized as a key intermediate in the synthesis of new drugs and medications, capitalizing on its ability to modify organic molecules and contribute to drug discovery.
Used in Material Science:
5-bromo-3-(phthalimidomethyl)pyridine also serves as a building block in the development of novel materials and chemical structures across various industrial applications, highlighting its multifaceted role in advancing chemical innovation.

Check Digit Verification of cas no

The CAS Registry Mumber 219660-71-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,9,6,6 and 0 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 219660-71:
(8*2)+(7*1)+(6*9)+(5*6)+(4*6)+(3*0)+(2*7)+(1*1)=146
146 % 10 = 6
So 219660-71-6 is a valid CAS Registry Number.

219660-71-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-[(5-bromopyridin-3-yl)methyl]isoindole-1,3-dione

1.2 Other means of identification

Product number -
Other names 2-(5-bromo-pyridin-3-ylmethyl)-isoindole-1,3-dione

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:219660-71-6 SDS

219660-71-6Relevant articles and documents

COMPOSITIONS AND METHODS FOR PARASITE CONTROL

-

Page/Page column 55; 71; 73-74, (2022/01/05)

The present invention relates in its broadest aspect to a compound of Formula I as provided herein, formulations comprising such a compound and corresponding uses thereof for the reduction of infestation with ectoparasites, in particular ectoparasites of the insect class, including fleas and mosquitoes and/or ectoparasites of the arachnid class, including ticks and mites, etc. Also provided herein are methods for preparing the formulations of the invention and methods for controlling ectoparasites using the compounds and/or formulations provided herein.

3-(1H-PYRROLO[2,3-C]PYRIDIN-2-YL)-1H-INDAZOLES AND THERAPEUTIC USES THEREOF

-

, (2017/03/08)

Indazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present disclosure concerns the use of an indazole compound or analogs thereof, in the treatment of disorders characterized by the activation of Wnt pathway signaling (e.g., cancer, abnormal cellular proliferation, angiogenesis, fibrotic disorders, bone or cartilage diseases, and osteoarthritis), the modulation of cellular events mediated by Wnt pathway signaling, as well as genetic diseases and neurological conditions/disorders/diseases due to mutations or dysregulation of the Wnt pathway and/or of one or more of Wnt signaling components. Also provided are methods for treating Wnt-related disease states.

3-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-1H-PYRAZOLO[4,3-B]PYRIDINES AND THERAPEUTIC USES THEREOF

-

, (2017/03/08)

4-Azaindazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present disclosure concerns the use of a 4-azaindazole compound or analogs thereof, in the treatment of disorders characterized by the activation of Wnt pathway signaling (e.g., cancer, abnormal cellular proliferation, angiogenesis, fibrotic disorders, bone or cartilage diseases, and osteoarthritis), the modulation of cellular events mediated by Wnt pathway signaling, as well as genetic diseases and neurological conditions/disorders/diseases due to mutations or dysregulation of the Wnt pathway and/or of one or more of Wnt signaling components. Also provided are methods for treating Wnt-related disease states.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 219660-71-6